CD4 and multiple sclerosis: In this line, we finally investigated EZH2 expression in chronic active lesions from 10 multiple sclerosis patients and observed that 8.5% (mean percentage) and 10.9% of the total CD4+ and CD8+ T cells were expressing EZH2 respectively (Fig. 5c).